查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球过敏注射市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按免疫疗法、按适应症、按过敏原、按分销管道、按地区
市场调查报告书
商品编码
1398829

全球过敏注射市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按免疫疗法、按适应症、按过敏原、按分销管道、按地区

Allergy Shots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 309 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球过敏注射剂市场经历了显着成长，预计将从 2024 年的约 26 亿美元增长到 2031 年底的 62 亿美元。

全球过敏注射市场正在经历强劲成长，这主要是由于全球各种过敏的发生率不断上升。 过敏性鼻炎 (AR)、非过敏性鼻炎 (NAR) 和非特异性鼻炎的中位盛行率分别为 29.4%、18.1% 和 12.0%，存在地区差异。 鼻炎发生率的增加，加上都市化文化、污染、不良饮食和饮酒，导致过敏反应迅速增加，包括食物过敏和皮肤过敏。 随着生活方式的发展，过敏注射治疗的需求不断增加，这是市场扩张的驱动力。

此外，由于特殊疗法和重组免疫疗法的进步，市场正在不断发展。 製造商正在积极寻求合併、收购、联盟和合作伙伴关係，以扩大其产品组合、扩大客户群并扩大其地理覆盖范围。

儘管市场成长前景广阔，但仍面临挑战。 过敏注射的治疗週期较长，长达3至5年，取决于过敏的性质和阶段。 患者经常因年龄、健康状况、地点或经济限製而停止治疗，阻碍了市场扩张。

此外，与过敏注射剂和片剂相关的副作用也导致了市场萎缩。 超过10%的患者会出现副作用，其中大多数是轻微到严重的局部反应，如口腔搔痒和喉咙不适。

本报告调查了全球过敏注射剂市场，并按产品、免疫疗法、适应症、过敏原、分销渠道、地区和市场进入对市场进行了概述。它提供了有关竞争趋势的信息公司。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第三章2018-2023年生产与贸易统计

第 4 章价格分析，2018-2023

第五章2018-2031 年全球过敏注射市场前景

  • 2018-2031 年全球过敏注射液市场前景（按产品、价值（百万美元）和数量（单位））
  • 2018-2031 年全球过敏注射市场前景（按免疫疗法分类）、价值（百万美元）、数量（单位）
  • 2018-2031 年全球过敏注射液市场前景，依适应症、价值（百万美元）、数量（单位）划分
  • 2018-2031 年全球过敏注射市场前景（按过敏原划分）、价值（百万美元）、数量（单位）
  • 2018-2031 年全球过敏注射液市场前景（按分销管道、价值（百万美元）、数量（单位））
  • 2018-2031 年全球过敏注射剂市场前景（按地区、价值（百万美元）、数量（单位））

第六章北美过敏注射液市场展望，2018-2031

第 7 章欧洲过敏注射剂市场前景，2018-2031

第 8 章亚太地区过敏注射剂市场展望，2018-2031

第 9 章拉丁美洲过敏注射剂市场展望，2018-2031

第10章中东及非洲过敏注射剂市场前景，2018-2031

第十一章竞争态势

  • 按类型与免疫疗法划分的热图
  • 製造商和免疫疗法的热图
  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Stallergenes Greer
    • Allergy Therapeutics
    • Aimmune Therapeutics
    • Anergis
    • Arrayit Corporation
    • Biomay AG
    • HAL Allergy Group
    • DBV Technologies

第12章附录

简介目录

The global Allergy Shots Market is poised for substantial growth, propelling the market valuation from approximately US$ 2.6 billion in 2024 to an estimated US$ 6.2 billion by the end of 2031.

Driving Factors

The global Allergy Shots Market is experiencing robust growth, primarily attributed to the escalating incidence of various allergy types worldwide. Allergic rhinitis (AR), non-allergic rhinitis (NAR), and nonspecific rhinitis have shown median prevalence rates of 29.4%, 18.1%, and 12.0%, respectively, with variations by region. This increasing frequency of rhinitis, combined with the adoption of urbanized cultures, pollution, poor dietary habits, and alcohol use, has led to a surge in allergic reactions, including food and skin allergies. As lifestyles evolve, the demand for allergy shots treatments is rising, driving market expansion.

Moreover, the market continually evolves with advancements in specialized therapeutics and recombinant immunotherapies. Manufacturers are embracing mergers, acquisitions, collaborations, and partnerships to broaden their product portfolios, extend their client base, and expand their geographic reach.

Challenges and Barriers

Despite its promising growth, the Allergy Shots Market faces challenges. The treatment course for Allergy Shots is lengthy, lasting up to 3 to 5 years depending on the allergy's nature and stage. Patients often discontinue treatment midway due to age, health, location, or financial constraints, hindering market expansion.

Additionally, adverse side effects associated with allergy injections and tablets have contributed to a market decline. More than 10% of patients reported experiencing adverse reactions, with the majority being mild to severe local reactions such as oral pruritus or throat discomfort.

Country-wise Insights

  • United States: The U.S. market is booming due to increased investments by regional key players in advanced product development, offering user-friendly solutions with rapid results. For example, Moonlight Therapeutics received $1.9 million in funding for preclinical investigations and product development for peanut allergy treatment.
  • Germany: Germany is emerging as a lucrative market with a focus on increasing product launches. In September 2019, the introduction of ITULAZAX, an efficient sublingual Allergy Shots tablet for tree pollen allergy, marked a significant development.
  • Japan: Japan is becoming a prominent market driven by the increasing prevalence of allergic rhinitis, affecting 10-30% of individuals globally. The high sensitivity of pollen from trees and grass in the region necessitates effective allergy treatments.

Competitive Landscape

The Allergy Shots Market is marked by a consolidated landscape with a small number of significant market players. Leading companies such as Aimmune Therapeutics, Hollister Allergy, Leti Pharma, and Merck KGaA are driving market growth through strategies like mergers and acquisitions, expansion, new product development, and alliances.

Key Companies Covered

  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Anergis
  • Arrayit Corporation
  • Biomay AG
  • HAL Allergy Group
  • DBV Technologies
  • ALK Abello

Key Segments Covered in Allergy Shots Industry Research

Product:

  • SLIT Tablets
    • Odactra
    • Grastek
    • Ragwitek
    • Oralair
    • Actair
    • Others
  • Oral
    • Palforzia
  • Others
    • Injections
    • Others

Immunotherapy:

  • Sublingual Immunotherapy (SLIT)
  • Subcutaneous Immunotherapy (SCIT)
    • Specific Immunotherapy
  • Others

Indication:

  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Atopic Dermatitis
  • Others

Allergen:

  • Pollens
    • Grass Pollens
    • Weed Pollens
    • Tree Pollens
      • House Dust Mites (HDM)
      • Mold
      • Animal Dander
      • Bee Venom
      • Cockroaches/Insects
      • Others

Distribution Channel:

  • Institutional Sales
    • Government Hospitals
    • Semi-Government Hospitals
    • Private Hospitals
  • Retail Sales
    • Retail Pharmacy
    • Drug Stores
    • Online Pharmacy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Allergy Shots Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Allergy Shots Market Production Output, by Region, Value (US$ Bn) and Volume ('000 Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Allergy Shots Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Allergy Shots Market Outlook, 2018 - 2031

  • 5.1. Global Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. SLIT Tablets
        • 5.1.1.1.1. Odactra
        • 5.1.1.1.2. Grastek
        • 5.1.1.1.3. Ragwitek
        • 5.1.1.1.4. Oralair
        • 5.1.1.1.5. Actair
        • 5.1.1.1.6. Others
      • 5.1.1.2. Oral
        • 5.1.1.2.1. Palforzia
        • 5.1.1.2.2. Others
      • 5.1.1.3. Injections
      • 5.1.1.4. Others
  • 5.2. Global Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Sublingual Immunotherapy (SLIT)
      • 5.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 5.2.1.2.1. Specific Immunotherapy
      • 5.2.1.3. Others
  • 5.3. Global Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Allergic Rhinitis
      • 5.3.1.2. Allergic Asthma
      • 5.3.1.3. Food Allergy
      • 5.3.1.4. Atopic Dermatitis
      • 5.3.1.5. Others
  • 5.4. Global Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Pollens
        • 5.4.1.1.1. Grass Pollens
        • 5.4.1.1.2. Weed Pollens
        • 5.4.1.1.3. Tree Pollens
      • 5.4.1.2. House Dust Mites (HDM)
      • 5.4.1.3. Mold
      • 5.4.1.4. Animal Dander
      • 5.4.1.5. Bee Venom
      • 5.4.1.6. Cockroaches/Insects
      • 5.4.1.7. Others
  • 5.5. Others Global Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Institutional Sales
        • 5.5.1.1.1. Government Hospitals
        • 5.5.1.1.2. Semi-Government Hospitals
        • 5.5.1.1.3. Private Hospitals
      • 5.5.1.2. Retail Sales
        • 5.5.1.2.1. Retail Pharmacy
        • 5.5.1.2.2. Drug Stores
        • 5.5.1.2.3. Online Pharmacy
  • 5.6. Global Allergy Shots Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.6.1. Key Highlights
      • 5.6.1.1. North America
      • 5.6.1.2. Europe
      • 5.6.1.3. Asia Pacific
      • 5.6.1.4. Latin America
      • 5.6.1.5. Middle East & Africa

6. North America Allergy Shots Market Outlook, 2018 - 2031

  • 6.1. North America Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. SLIT Tablets
        • 6.1.1.1.1. Odactra
        • 6.1.1.1.2. Grastek
        • 6.1.1.1.3. Ragwitek
        • 6.1.1.1.4. Oralair
        • 6.1.1.1.5. Actair
        • 6.1.1.1.6. Others
      • 6.1.1.2. Oral
        • 6.1.1.2.1. Palforzia
        • 6.1.1.2.2. Others
      • 6.1.1.3. Injections
      • 6.1.1.4. Others
  • 6.2. North America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Sublingual Immunotherapy (SLIT)
      • 6.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 6.2.1.2.1. Specific Immunotherapy
      • 6.2.1.3. Others
  • 6.3. North America Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Allergic Rhinitis
      • 6.3.1.2. Allergic Asthma
      • 6.3.1.3. Food Allergy
      • 6.3.1.4. Atopic Dermatitis
      • 6.3.1.5. Others
  • 6.4. North America Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Pollens
        • 6.4.1.1.1. Grass Pollens
        • 6.4.1.1.2. Weed Pollens
        • 6.4.1.1.3. Tree Pollens
      • 6.4.1.2. House Dust Mites (HDM)
      • 6.4.1.3. Mold
      • 6.4.1.4. Animal Dander
      • 6.4.1.5. Bee Venom
      • 6.4.1.6. Cockroaches/Insects
      • 6.4.1.7. Others
  • 6.5. North America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. Institutional Sales
        • 6.5.1.1.1. Government Hospitals
        • 6.5.1.1.2. Semi-Government Hospitals
        • 6.5.1.1.3. Private Hospitals
      • 6.5.1.2. Retail Sales
        • 6.5.1.2.1. Retail Pharmacy
        • 6.5.1.2.2. Drug Stores
        • 6.5.1.2.3. Online Pharmacy
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis
  • 6.6. North America Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1. Key Highlights
      • 6.6.1.1. U.S. Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.2. U.S. Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.3. U.S. Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.4. U.S. Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.5. U.S. Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.6. Canada Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.7. Canada Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.8. Canada Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.9. Canada Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.10. Canada Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Allergy Shots Market Outlook, 2018 - 2031

  • 7.1. Europe Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. SLIT Tablets
        • 7.1.1.1.1. Odactra
        • 7.1.1.1.2. Grastek
        • 7.1.1.1.3. Ragwitek
        • 7.1.1.1.4. Oralair
        • 7.1.1.1.5. Actair
        • 7.1.1.1.6. Others
      • 7.1.1.2. Oral
        • 7.1.1.2.1. Palforzia
        • 7.1.1.2.2. Others
      • 7.1.1.3. Injections
      • 7.1.1.4. Others
  • 7.2. Europe Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Sublingual Immunotherapy (SLIT)
      • 7.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 7.2.1.2.1. Specific Immunotherapy
      • 7.2.1.3. Others
  • 7.3. Europe Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Allergic Rhinitis
      • 7.3.1.2. Allergic Asthma
      • 7.3.1.3. Food Allergy
      • 7.3.1.4. Atopic Dermatitis
      • 7.3.1.5. Others
  • 7.4. Europe Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Pollens
        • 7.4.1.1.1. Grass Pollens
        • 7.4.1.1.2. Weed Pollens
        • 7.4.1.1.3. Tree Pollens
      • 7.4.1.2. House Dust Mites (HDM)
      • 7.4.1.3. Mold
      • 7.4.1.4. Animal Dander
      • 7.4.1.5. Bee Venom
      • 7.4.1.6. Cockroaches/Insects
      • 7.4.1.7. Others
  • 7.5. Europe Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Institutional Sales
        • 7.5.1.1.1. Government Hospitals
        • 7.5.1.1.2. Semi-Government Hospitals
        • 7.5.1.1.3. Private Hospitals
      • 7.5.1.2. Retail Sales
        • 7.5.1.2.1. Retail Pharmacy
        • 7.5.1.2.2. Drug Stores
        • 7.5.1.2.3. Online Pharmacy
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis
  • 7.6. Europe Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1. Key Highlights
      • 7.6.1.1. Germany Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.2. Germany Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.3. Germany Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.4. Germany Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.5. Germany Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.6. U.K. Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.7. U.K. Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.8. U.K. Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.9. U.K. Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.10. U.K. Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.11. France Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.12. France Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.13. France Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.14. France Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.15. France Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.16. Italy Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.17. Italy Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.18. Italy Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.19. Italy Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.20. Italy Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.21. Turkey Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.22. Turkey Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.23. Turkey Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.24. Turkey Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.25. Turkey Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.26. Russia Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.27. Russia Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.28. Russia Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.29. Russia Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.30. Russia Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.31. Rest of Europe Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.32. Rest of Europe Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.33. Rest of Europe Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.34. Rest of Europe Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.35. Rest of Europe Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Allergy Shots Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. SLIT Tablets
        • 8.1.1.1.1. Odactra
        • 8.1.1.1.2. Grastek
        • 8.1.1.1.3. Ragwitek
        • 8.1.1.1.4. Oralair
        • 8.1.1.1.5. Actair
        • 8.1.1.1.6. Others
      • 8.1.1.2. Oral
        • 8.1.1.2.1. Palforzia
        • 8.1.1.2.2. Others
      • 8.1.1.3. Injections
      • 8.1.1.4. Others
  • 8.2. Asia Pacific Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Sublingual Immunotherapy (SLIT)
      • 8.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 8.2.1.2.1. Specific Immunotherapy
      • 8.2.1.3. Others
  • 8.3. Asia Pacific Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Allergic Rhinitis
      • 8.3.1.2. Allergic Asthma
      • 8.3.1.3. Food Allergy
      • 8.3.1.4. Atopic Dermatitis
      • 8.3.1.5. Others
  • 8.4. Asia Pacific Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Pollens
        • 8.4.1.1.1. Grass Pollens
        • 8.4.1.1.2. Weed Pollens
        • 8.4.1.1.3. Tree Pollens
      • 8.4.1.2. House Dust Mites (HDM)
      • 8.4.1.3. Mold
      • 8.4.1.4. Animal Dander
      • 8.4.1.5. Bee Venom
      • 8.4.1.6. Cockroaches/Insects
      • 8.4.1.7. Others
  • 8.5. Asia Pacific Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. Institutional Sales
        • 8.5.1.1.1. Government Hospitals
        • 8.5.1.1.2. Semi-Government Hospitals
        • 8.5.1.1.3. Private Hospitals
      • 8.5.1.2. Retail Sales
        • 8.5.1.2.1. Retail Pharmacy
        • 8.5.1.2.2. Drug Stores
        • 8.5.1.2.3. Online Pharmacy
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis
  • 8.6. Asia Pacific Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1. Key Highlights
      • 8.6.1.1. China Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.2. China Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.3. China Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.4. China Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.5. China Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.6. Japan Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.7. Japan Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.8. Japan Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.9. Japan Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.10. Japan Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.11. South Korea Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.12. South Korea Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.13. South Korea Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.14. South Korea Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.15. South Korea Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.16. India Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.17. India Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.18. India Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.19. India Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.20. India Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.21. Southeast Asia Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.22. Southeast Asia Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.23. Southeast Asia Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.24. Southeast Asia Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.25. Southeast Asia Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.26. Rest of Asia Pacific Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.27. Rest of Asia Pacific Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.28. Rest of Asia Pacific Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.29. Rest of Asia Pacific Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.30. Rest of Asia Pacific Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Allergy Shots Market Outlook, 2018 - 2031

  • 9.1. Latin America Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. SLIT Tablets
        • 9.1.1.1.1. Odactra
        • 9.1.1.1.2. Grastek
        • 9.1.1.1.3. Ragwitek
        • 9.1.1.1.4. Oralair
        • 9.1.1.1.5. Actair
        • 9.1.1.1.6. Others
      • 9.1.1.2. Oral
        • 9.1.1.2.1. Palforzia
        • 9.1.1.2.2. Others
      • 9.1.1.3. Injections
      • 9.1.1.4. Others
  • 9.2. Latin America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.2.1.1. Sublingual Immunotherapy (SLIT)
      • 9.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 9.2.1.2.1. Specific Immunotherapy
      • 9.2.1.3. Others
  • 9.3. Latin America Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Allergic Rhinitis
      • 9.3.1.2. Allergic Asthma
      • 9.3.1.3. Food Allergy
      • 9.3.1.4. Atopic Dermatitis
      • 9.3.1.5. Others
  • 9.4. Latin America Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Pollens
        • 9.4.1.1.1. Grass Pollens
        • 9.4.1.1.2. Weed Pollens
        • 9.4.1.1.3. Tree Pollens
      • 9.4.1.2. House Dust Mites (HDM)
      • 9.4.1.3. Mold
      • 9.4.1.4. Animal Dander
      • 9.4.1.5. Bee Venom
      • 9.4.1.6. Cockroaches/Insects
      • 9.4.1.7. Others
  • 9.5. Latin America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.5.1. Key Highlights
      • 9.5.1.1. Institutional Sales
        • 9.5.1.1.1. Government Hospitals
        • 9.5.1.1.2. Semi-Government Hospitals
        • 9.5.1.1.3. Private Hospitals
      • 9.5.1.2. Retail Sales
        • 9.5.1.2.1. Retail Pharmacy
        • 9.5.1.2.2. Drug Stores
        • 9.5.1.2.3. Online Pharmacy
    • 9.5.2. BPS Analysis/Market Attractiveness Analysis
  • 9.6. Latin America Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1. Key Highlights
      • 9.6.1.1. Brazil Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.2. Brazil Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.3. Brazil Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.4. Brazil Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.5. Brazil Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.6. Mexico Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.7. Mexico Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.8. Mexico Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.9. Mexico Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.10. Mexico Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.11. Argentina Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.12. Argentina Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.13. Argentina Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.14. Argentina Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.15. Argentina Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.16. Rest of Latin America Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.17. Rest of Latin America Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.18. Rest of Latin America Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.19. Rest of Latin America Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.20. Rest of Latin America Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Allergy Shots Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. SLIT Tablets
        • 10.1.1.1.1. Odactra
        • 10.1.1.1.2. Grastek
        • 10.1.1.1.3. Ragwitek
        • 10.1.1.1.4. Oralair
        • 10.1.1.1.5. Actair
        • 10.1.1.1.6. Others
      • 10.1.1.2. Oral
        • 10.1.1.2.1. Palforzia
        • 10.1.1.2.2. Others
      • 10.1.1.3. Injections
      • 10.1.1.4. Others
  • 10.2. Middle East & Africa Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Sublingual Immunotherapy (SLIT)
      • 10.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 10.2.1.2.1. Specific Immunotherapy
      • 10.2.1.3. Others
  • 10.3. Middle East & Africa Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Allergic Rhinitis
      • 10.3.1.2. Allergic Asthma
      • 10.3.1.3. Food Allergy
      • 10.3.1.4. Atopic Dermatitis
      • 10.3.1.5. Others
  • 10.4. Middle East & Africa Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. Cell Wall Synthesis Inhibitors
      • 10.4.1.2. Protein Synthesis Inhibitors
      • 10.4.1.3. DNA Synthesis Inhibitors
      • 10.4.1.4. RNA Synthesis Inhibitors
      • 10.4.1.5. Others
  • 10.5. Middle East & Africa Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.5.1. Key Highlights
      • 10.5.1.1. Institutional Sales
        • 10.5.1.1.1. Government Hospitals
        • 10.5.1.1.2. Semi-Government Hospitals
        • 10.5.1.1.3. Private Hospitals
      • 10.5.1.2. Retail Sales
        • 10.5.1.2.1. Retail Pharmacy
        • 10.5.1.2.2. Drug Stores
        • 10.5.1.2.3. Online Pharmacy
    • 10.5.2. BPS Analysis/Market Attractiveness Analysis
  • 10.6. Middle East & Africa Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1. Key Highlights
      • 10.6.1.1. GCC Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.2. GCC Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.3. GCC Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.4. GCC Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.5. GCC Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.6. South Africa Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.7. South Africa Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.8. South Africa Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.9. South Africa Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.10. South Africa Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.11. Egypt Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.12. Egypt Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.13. Egypt Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.14. Egypt Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.15. Egypt Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.16. Nigeria Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.17. Nigeria Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.18. Nigeria Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.19. Nigeria Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.20. Nigeria Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.21. Rest of Middle East & Africa Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.22. Rest of Middle East & Africa Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.23. Rest of Middle East & Africa Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.24. Rest of Middle East & Africa Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.25. Rest of Middle East & Africa Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By Species vs by Immunotherapy Heat map
  • 11.2. Manufacturer vs by Immunotherapy Heat map
  • 11.3. Company Market Share Analysis, 2023
  • 11.4. Competitive Dashboard
  • 11.5. Company Profiles
    • 11.5.1. Stallergenes Greer
      • 11.5.1.1. Company Overview
      • 11.5.1.2. Product Portfolio
      • 11.5.1.3. Financial Overview
      • 11.5.1.4. Business Strategies and Development
    • 11.5.2. Allergy Therapeutics
      • 11.5.2.1. Company Overview
      • 11.5.2.2. Product Portfolio
      • 11.5.2.3. Financial Overview
      • 11.5.2.4. Business Strategies and Development
    • 11.5.3. Aimmune Therapeutics
      • 11.5.3.1. Company Overview
      • 11.5.3.2. Product Portfolio
      • 11.5.3.3. Financial Overview
      • 11.5.3.4. Business Strategies and Development
    • 11.5.4. Anergis
      • 11.5.4.1. Company Overview
      • 11.5.4.2. Product Portfolio
      • 11.5.4.3. Financial Overview
      • 11.5.4.4. Business Strategies and Development
    • 11.5.5. Arrayit Corporation
      • 11.5.5.1. Company Overview
      • 11.5.5.2. Product Portfolio
      • 11.5.5.3. Financial Overview
      • 11.5.5.4. Business Strategies and Development
    • 11.5.6. Biomay AG
      • 11.5.6.1. Company Overview
      • 11.5.6.2. Product Portfolio
      • 11.5.6.3. Financial Overview
      • 11.5.6.4. Business Strategies and Development
    • 11.5.7. HAL Allergy Group
      • 11.5.7.1. Company Overview
      • 11.5.7.2. Product Portfolio
      • 11.5.7.3. Financial Overview
      • 11.5.7.4. Business Strategies and Development
    • 11.5.8. DBV Technologies
      • 11.5.8.1. Company Overview
      • 11.5.8.2. Product Portfolio
      • 11.5.8.3. Financial Overview
      • 11.5.8.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations